James E. Bradner stock trades
EVP, Research and Development of Amgen
No open-market buys or sales reported in the last 12 months. Their newest Form 4, for May 7: tax withholding (446 AMGN shares).
Where James E. Bradner files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 0 |
James E. Bradner's trades, as filed
None on the open market in the last 12 months.
4 other filings on record (tax withholdings and stock award). Pro members see every filing and the shares James E. Bradner holds.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
Others who file at Amgen
- Robert A. Bradway
- Peter H. Griffith
- Nancy A. Grygiel
- Rachna Khosla
- Derek Miller
- Esteban Santos
- Matthew C. Busch
- Murdo Gordon
- David M. Reese
- Jonathan P. Graham
- Ellen Jamison Kullman
- Amy E. Miles
- Brian Druker
- Charles M. Holley
- Greg C. Garland
- Mary E. Klotman
- Michael V. Drake
- Omar Ishrak
- Robert Eckert
- Tyler Jacks
- Wanda M. Austin